eScholarship
metadata only
SARS-CoV-2 vaccination protects against infection-induced autoantibody formation 2302309
Abstract Introduction SARS-CoV-2-CoV-2 infection is known to induce autoantibodies across a wide range of targets, including immune modulatory proteins and pro-thrombotic factors. It is not known if vaccination with SARS-CoV-2 mRNA vaccines would induce a similar autoantibody profile, or whether pr
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations#311168
- Booster Immunization Study of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)#148548
- A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19#1140362
- Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Phase III#830376
- Safety and Immunogenicity of a Booster Vaccination With an Adapted Vaccine#1337590
Record · ID 1250199
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive